Literature DB >> 27066493

Two Cases of Hypophosphatemia with Increased Renal Phosphate Excretion in Legionella Pneumonia.

Shuhei Watanabe1, Keiji Kono1, Hideki Fujii2, Kentaro Nakai2, Shunsuke Goto2, Shinichi Nishi2.   

Abstract

We encountered 2 cases of hypophosphatemia due to Legionella pneumonia. Both cases showed increased urinary phosphate excretion and renal tubular dysfunction, which ameliorated with recovery from Legionella pneumonia. Serum fibroblast growth factor-23 level was suppressed, whereas serum 1,25(OH)2 vitamin D and parathyroid hormone levels were normal. Delayed elevation of serum 1,25(OH)2 vitamin D levels was observed with improvement in renal tubular function. These findings suggested hypophosphatemia might be mediated by renal tubular dysfunction.

Entities:  

Keywords:  1,25(OH)2 vitamin D; Fibroblast growth factor-23; Hypophosphatemia; Legionella pneumonia; Renal tubular dysfunction

Year:  2016        PMID: 27066493      PMCID: PMC4821156          DOI: 10.1159/000444875

Source DB:  PubMed          Journal:  Case Rep Nephrol Dial


Background

Legionella pneumophila is a common cause of community-acquired pneumonia. It is well known that patients with Legionella pneumonia present with multisystemic extrapulmonary manifestations, such as electrolyte disorders, renal dysfunction, and liver dysfunction [1]. Among the electrolyte disorders, hypophosphatemia is noted as one of the common features and is used as part of the diagnostic criteria for Legionella pneumonia [2]. However, its detailed mechanism remains unclear. In general, phosphate homeostasis is mainly regulated by the endocrine system, specifically by parathyroid hormone (PTH), 1,25(OH)2 vitamin D, and fibroblast growth factor-23 (FGF-23) [3]. We report 2 cases of Legionella pneumonia compli cated with hypophosphatemia and the evaluated mineral homeostatic regulators associated with phosphate control.

Case Presentations

Case 1

A 54-year-old male visited the emergency department because of fatigue and fever a day before admission. He did not have any respiratory or abdominal symptoms. The patient's medical history revealed that he had started treatment for hypertension 3 years ago and that he had been prescribed valsartan (80 mg/day) and amlodipine (5 mg/day). Physical examination showed a BMI of 27.5 kg/m2, blood pressure of 156/96 mm Hg, pulse rate of 137 bpm, temperature of 40.1°C, oxygen saturation of 95% (room air), and crackles at the base of the right lung. CT was performed, and ground-glass opacities were detected in the right middle and lower lobes. Considering these clinical findings together with a positive urinary test for Legionella antigen (Binax, Portland, Maine, USA), a diagnosis of Legionella pneumonia was confirmed. Laboratory data on admission are summarized in table 1. The patient had mild renal dysfunction and hypophosphatemia, while the other electrolytes were within the normal range. Glycemic control was within the ideal range. Arterial blood gas measurement demonstrated hypoxemia and mild respiratory alkalosis. Furthermore, urinary analysis revealed proteinuria, glycosuria, panaminoaciduria, and phosphaturia. Urinary N-acetyl-D-glucosaminidase (U-NAG) and urinary β2-microglobulin (U-β2-MG) levels were also elevated.
Table 1

Laboratory findings on admission

ReferencePatient 1Patient 2
Biochemistry (serum)
 Creatinine, mg/dl0.5–1.21.390.88
 eGFR, ml/min/1.73 m243.165.6
 Urea nitrogen, mg/dl8.0–20.020.218.4
 Sodium, mEq/l135–147137132
 Potassium, mEq/l3.3–4.83.64.1
 Chloride, mEq/l98–108101102
 Phosphate, mg/dl2.7–4.71.21.8
 Corrected calcium, mg/dl8.6–11.08.79.3
 Magnesium, mg/dl1.7–2.41.82.1
 CRP, mg/dl0–0.325.330.9
 Glucose, mg/dl70–109141176

Blood gasses
 pH7.35–7.457.4857.458
 pCO2, mm Hg35–4530.927.7
 HCO3, mmol/l23–2822.819.1

Urinalysis
 pH4.8–7.56.56.0
 Proteinuria4+2+
 Proteinuria, g/gCr0.41.1
 Glucose2+2+
 Glucose, mg/dl0–30469926
 NAG, IU/l0–7.411.316.6
 β2-MG, μg/l20–30054,40080,800
 TRP, %8774
 TmP/GFR1.81.32
 Panaminoaciduria++

Mineral homeostatic regulators
 1,25(OH)2 vitamin D, pg/ml20.0–60.057.2
 i-PTH, pg/ml15.0–68.030
 FGF-23, pg/ml<5

eGFR = Estimated GFR; TRP = tubular reabsorption of phosphate.

After initiation of antibiotic therapy, serum C-reactive protein (CRP) levels improved (fig. 1). The elevation of U-NAG and U-β2-MG also improved with recovery from pneumonia. Glycosuria, proteinuria, panaminoaciduria, and phosphaturia also improved rapidly. Serum phosphate and ratio of maximal tubular reabsorption of phosphorus/glomerular filtration rate (TmP/GFR) levels reached the normal range on the 5th day after admission.
Fig. 1

Clinical course of case 1. CPFX = Ciprofloxacin; AZM = azithromycin; P = phosphate.

Case 2

A 71-year-old male presented with fever, nausea, and fatigue 3 days before admission. He did not have any respiratory or abdominal symptoms. He had been previously healthy and had not taken any drugs. Physical examination showed a BMI of 21.7 kg/m2, blood pressure of 140/90 mm Hg, pulse rate of 102 bpm, temperature of 40.1°C, oxygen saturation of 95% (2 liter/min, nasal cannula), and crackles in the left lung. Chest CT showed ground-glass opacities in all lobes of the left lung. A urinary test for Legionella antigen was positive, and the diagnosis of Legionella pneumonia was confirmed. Laboratory analyses on admission are summarized in table 1. Serum creatinine levels were within the normal range (0.88 mg/dl), and estimated GFR was 65.6 ml/min/1.73 m2. Arterial blood gas measurement revealed hypoxemia and mild respiratory alkalosis. Hypophosphatemia, phosphaturia, and renal tubular dysfunction were also present. As for mineral homeostatic regulators, serum FGF-23 level was unmeasurably low, 1,25(OH)2 vitamin D was within the normal range (57.2 pg/ml, normal range: 20.0–60.0), and intact PTH (i-PTH) was not elevated (30 pg/ml, normal range: 15.0–68.0) on admission. After administration of ciprofloxacin at 600 mg/day, the levels of serum CRP, U-NAG, and U-β2-MG improved (fig. 2). Renal tubular dysfunction, including glycosuria, proteinuria, panaminoaciduria, and phosphaturia, improved with recovery from pneumonia. Delayed elevation of 1,25(OH)2 vitamin D levels was present on the 3rd day after admission. Serum FGF-23 levels gradually increased with improvement in renal tubular dysfunction, serum phosphate, and TmP/GFR levels. Serum i-PTH levels did not increase during the whole period.
Fig. 2

Clinical course of case 2. CPFX = Ciprofloxacin; CAM = clarithromycin; P = phosphate.

Discussion

Hypophosphatemia is a common complication associated with Legionella pneumonia, although the underlying mechanism is unclear [1]. We presented 2 cases of Legionella pneumonia with hypophosphatemia. Both showed increased renal phosphate excretion on admission, which rapidly resolved during recovery from Legionella pneumonia. Renal phosphate reabsorption takes place mostly in the proximal renal tubules. In general, the etiology of increased renal phosphate excretion includes 2 main causes: proximal renal tubular dysfunction, such as Fanconi syndrome, and a disorder of the physiological mineral homeostatic regulators such as FGF-23, PTH, and 1,25(OH)2 vitamin D [4]. The present cases demonstrated elevated U-NAG and U-β2-MG levels, proteinuria, glycosuria, and panaminoaciduria, all of which resolved rapidly with improvement of Legionella pneumonia. These findings suggest that proximal renal tubular dysfunction may occur transiently in cases of Legionella pneumonia. A recent report also demonstrated that Legionella pneumonia triggered the acquired Fanconi syndrome [5]. However, no report has measured mineral homeostatic regulators in Legionella pneumonia. In the present case 2, serum FGF-23 level was unmeasurably low on admission and gradually increased as serum phosphate levels normalized, whereas serum PTH levels were not elevated during the whole period. These results suggest that both FGF-23 and PTH were not responsible for hypophosphatemia in Legionella pneumonia. Serum 1,25(OH)2 vitamin D level was within the normal range on admission despite the presence of severe hypophosphatemia. Three days after admission, delayed elevation of serum 1,25(OH)2 vitamin D level was observed with improvement of renal tubular dysfunction. Hypophosphatemia has been postulated to accelerate the production of 1,25(OH)2 vitamin D through the activation of cytochrome p450 27B1 (CYP27B1) in renal proximal tubules [6, 7]. Previous reports have mentioned that impaired activation of 1,25(OH)2 vitamin D is induced by proximal renal tubular dysfunction associated with tubulointerstitial nephritis or Fanconi syndrome [8, 9]. Taking these facts into consideration, we speculated that there was a possibility that proximal renal tubular dysfunction caused the delayed elevation of 1,25(OH)2 vitamin D. It could be one of the additive reasons for hypophosphatemia in Legionella pneumonia. Interestingly, serum FGF-23 levels gradually increased with improvement in renal tubular function, serum phosphate, and TmP/GFR levels. Although the regulator of FGF-23 is still not fully understood, the time course of serum FGF-23 levels gives us speculation that renal tubular function, renal phosphate excretion, and serum phosphate levels might contribute to the regulation of FGF-23 secretion. Known causes of proximal renal tubular dysfunction include congenital diseases, adverse drug reactions, M-protein disorders, collagen diseases, and exposure to heavy metals [10]. In the present cases, proximal renal tubular dysfunction could have been caused by Legionella pneumonia itself because the findings of renal tubular dysfunction were resolved when Legionella pneumonia improved, and the patients did not have any other causes. However, its mechanism remains unclear. Legionella pneumophila is a well-known facultative intracellular bacterium. To avoid interaction with host cell lysosomes and proliferative pathogens, Legionella pneumophila requires components of many host cell organelles, such as endosomes, mitochondria, ribosomes, and endoplasmic reticulum [11]. As for renal complications, tubulointerstitial nephritis and the presence of Legionella pneumophila itself were confirmed by renal biopsy [12, 13, 14]. Histologically, renal proximal tubules include numerous mitochondria required to supply energy for reabsorption [15]. Considering these features, we speculated that renal proximal tubules might be the most susceptible tissues because of the presence of mitochondria-rich lesions. As a limitation, we evaluated mineral homeostatic regulators in only 1 of the present cases. However, there were no previous reports that showed its regulators in Legionella pneumonia, and thereby we considered that the present cases were worth reporting. In conclusion, our cases suggested that hypophosphatemia due to Legionella pneumonia was caused not by FGF-23 and PTH but by renal tubular dysfunction. Furthermore, delayed 1,25(OH)2 vitamin D activation may initially affect hypophosphatemia.

Statement of Ethics

The authors have no ethical conflicts to disclose.

Disclosure Statement

The authors have no conflicts of interest to disclose.
  15 in total

Review 1.  Molecular pathogenesis of infections caused by Legionella pneumophila.

Authors:  Hayley J Newton; Desmond K Y Ang; Ian R van Driel; Elizabeth L Hartland
Journal:  Clin Microbiol Rev       Date:  2010-04       Impact factor: 26.132

2.  Cloning and expression of rat 25-hydroxyvitamin D3-1alpha-hydroxylase cDNA.

Authors:  T Shinki; H Shimada; S Wakino; H Anazawa; M Hayashi; T Saruta; H F DeLuca; T Suda
Journal:  Proc Natl Acad Sci U S A       Date:  1997-11-25       Impact factor: 11.205

Review 3.  Hypophosphatemia: an update on its etiology and treatment.

Authors:  André Gaasbeek; A Edo Meinders
Journal:  Am J Med       Date:  2005-10       Impact factor: 4.965

4.  Phosphate deprivation increases serum 1,25-(OH)2-vitamin D concentrations in healthy men.

Authors:  W J Maierhofer; R W Gray; J Lemann
Journal:  Kidney Int       Date:  1984-03       Impact factor: 10.612

5.  Metabolism of calcium and vitamin D3 in patients with acute tubulointerstitial nephritis: a study of 41 patients with nephropathia epidemica.

Authors:  H Saha; J Mustonen; K Pietilä; A Pasternack
Journal:  Nephron       Date:  1993       Impact factor: 2.847

6.  Vitamin D metabolites and osteomalacia in the human Fanconi syndrome.

Authors:  G Colussi; M E De Ferrari; M Surian; F Malberti; G Rombolà; G Pontoriero; G Galvanini; L Minetti
Journal:  Proc Eur Dial Transplant Assoc Eur Ren Assoc       Date:  1985

7.  Extrathoracic localization of Legionella pneumophila in Legionnaires' pneumonia.

Authors:  C P Evans; W C Winn
Journal:  Am J Clin Pathol       Date:  1981-12       Impact factor: 2.493

Review 8.  Proximal renal tubular acidosis: a not so rare disorder of multiple etiologies.

Authors:  Syed K Haque; Gema Ariceta; Daniel Batlle
Journal:  Nephrol Dial Transplant       Date:  2012-12       Impact factor: 5.992

Review 9.  Legionnaires' disease: clinical differentiation from typical and other atypical pneumonias.

Authors:  Burke A Cunha
Journal:  Infect Dis Clin North Am       Date:  2010-03       Impact factor: 5.982

10.  Acquired Fanconi syndrome in patients with Legionella pneumonia.

Authors:  Naoko Kinoshita-Katahashi; Hirotaka Fukasawa; Sayaka Ishigaki; Shinsuke Isobe; Shiro Imokawa; Yoshihide Fujigaki; Ryuichi Furuya
Journal:  BMC Nephrol       Date:  2013-08-02       Impact factor: 2.388

View more
  4 in total

1.  Significance of Hypophosphatemia in Patients with Pneumonia.

Authors:  Yasuhiro Morimoto; Takashi Ishiguro; Ryuji Uozumi; Kenji Takano; Yoichi Kobayashi; Yasuhito Kobayashi; Yoshihiko Shimizu; Noboru Takayanagi
Journal:  Intern Med       Date:  2022-04-01       Impact factor: 1.282

2.  Legionella Pneumonia Complicated with Acquired Fanconi Syndrome.

Authors:  Ryo Koda; Ryo Itoh; Masafumi Tsuchida; Kazumasa Ohashi; Noriaki Iino; Toshinori Takada; Ichiei Narita
Journal:  Intern Med       Date:  2018-06-06       Impact factor: 1.271

3.  Lower serum phosphate levels in patients with Legionella pneumonia relative to patients with non-Legionella pneumonia.

Authors:  Mikio Wada; Atsushi Kawashima
Journal:  J Family Med Prim Care       Date:  2021-11-29

4.  Acquired Fanconi Syndrome in a Patient with Nontyphoidal Salmonella Bacteremia.

Authors:  Akihiro Ryuge; Shoji Saito; Hiroshi Morioka; Asaka Hachiya; Noritoshi Kato; Takuji Ishimoto; Tomoki Kosugi; Shoichi Maruyama
Journal:  Intern Med       Date:  2020-09-30       Impact factor: 1.271

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.